Synlogic Announces Underwriters’ Option Exercise in Full

Published: 1/02/2018
Synlogic Announces Underwriters’ Option Exercise in Full
Source: WWW.BUSINESSWIRE.COM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced it has issued an additional 769,500 shares of common stock at the public offering price of $9.75 per share, resulting in additional gross proceeds of approximately $7.5 million, pursuant to the exercise of the underwriters’

Read more
Related news
Comment